Skip to content
Open access

Biobank-scale genotype similarity search and dynamic patient-matched cohort creation with GenoSiS

Jul 2026 · Genome Research · Vol 36, pp. 1624 - 1636 · 0 citations · 32 references
Medicine

TL;DR

GenoSiS leverages machine learning–based similarity search to dynamically find patient-matched cohorts across different populations quickly, which could serve as reference cohorts to improve a range of clinical analyses, including disease risk score calculations and dosage decisions.

Abstract

Many patients do not experience optimal benefits from medical advances because clinical research does not adequately represent them. Although the diversity of biomedical research cohorts is improving, ensuring that individual patients are adequately represented remains challenging. We propose a new approach, GenoSiS, which leverages machine learning–based similarity search to dynamically find patient-matched cohorts across different populations quickly. These cohorts could serve as reference cohorts to improve a range of clinical analyses, including disease risk score calculations and dosage decisions. Although GenoSiS focuses on finding genetic similarity within a biobank, our similarity search architecture can be extended to represent other medically relevant patient characteristics and search other biobanks.

Read PDF

Similar papers

Review Sep 2026

Representative Biobanks as Infrastructure for Equitable Precision Medicine: Implications for Clinical Trials, Artificial Intelligence, and Translational Research.

The shift toward precision medicine has transformed clinical trial design and drug delivery, yet persistent gaps in data diversity continue to contribute to health disparities. Broad representation and precision stratification are not competing goals; rather, representative datasets are the necessary foundation for ide...

Meghan Davis, Carla Reimold, Kirk Taylor et al. · 0 citations
Sep 2026

The GenV Biobank: Enabling Biological Research in a Large Longitudinal Population-Representative Cohort of Australian Newborns and Their Parents.

Generation Victoria (GenV), Australia's largest population-representative cohort study, has established a scalable and pragmatic approach to biobanking. This article describes the guiding principles used to overcome previous obstacles and build this unique population-representative mega-cohort birth biobank. By prospec...

K. Lange, Kim L. Powell, Y. Mangwiro et al. · 0 citations
Open access 2026

Integrating Genomic and Phenotypic Data for Gene Prioritization: AI Performance Assessment of the InheriNext® Algorithm

This study presents a comprehensive benchmark analysis of InheriNext®, a domain-specific, AI-powered tool designed for phenotype-driven pathogenic variant prioritization. For this study, 7,244 whole exome test cases were generated using phenotype and genotype data from Phenopackets, along with pools of variants from he...

Justin Chang, Kuan Li, Yu-Shen Tsai et al. · 0 citations
#federated learning Review Open access Sep 2026

Biological Foundation Models for Complex Disease Research and Clinical Translation

Biological foundation models are new artificial intelligence tools that can learn useful patterns from large biological datasets and apply them to different research questions to help researchers understand disease mechanisms, identify important genetic changes, predict drug responses, and discover treatment targets.

Tiana Noll-Walker, Yong Chen · 0 citations
Open access Sep 2026

SPLENDID incorporates continuous genetic ancestry in biobank-scale data to improve polygenic risk prediction across diverse populations

It is shown that SPLENDID significantly improved prediction accuracy over existing methods, particularly for non-European and admixed ancestries, particularly for non-European and admixed ancestries.

Tony Chen, Hao-Yu Zhang, R. Mazumder et al. · 0 citations
Review Aug 2026

Integrating population heterogeneity in drug research and early development: a proactive strategy.

Population heterogeneity in disease biology, drug exposure and treatment response is often addressed only after development has progressed, limiting generalizability and increasing late-stage risk. We propose an anticipate-verify-influence framework to integrate clinically relevant variability from research through dev...

T. Lavé, Bruno Jolain, Ken Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.